All Stories

  1. 37th European Congress of Pathology - Abstracts
  2. Herpes Simplex Virus Type-1 Infection as a Trigger for Pemphigus Vulgaris
  3. Buschke-Lowenstein Tumor: An Unusual Therapeutic Approach
  4. Cutaneous lesions and articular manifestations in multicentric reticulohistiocytosis: a diagnostic challenge
  5. Recapitulation of clinical features in a patient-derived xenograft mouse model of VEXAS Syndrome
  6. Histopathological and Clinical-Genetic Analysis of Corneal Specimens in Maroteaux–Lamy Syndrome
  7. Expert consensus and current landscape of NUT carcinoma: A comprehensive strategy from diagnosis to treatment
  8. Biomarker Profiling of Upper Tract Urothelial Carcinoma Only and with Synchronous or Metachronous Bladder Cancer
  9. Recapitulation of clinical features in a patient-derived xenograft mouse model of VEXAS Syndrome
  10. Cellular iron governs the host response to malaria
  11. LINFOMA DE HODGKIN
  12. Author Reply to Peer Reviews of Cellular iron governs the host response to malaria
  13. Generation of an Obese Diabetic Mouse Model upon Conditional Atrx Disruption
  14. Renovascular Hypertension: Unraveling a Case of Mixed Histiocytosis
  15. Abstract
  16. Cellular iron governs the host response to malaria
  17. Prognostic Value of Bladder Involvement in the Outcome of Upper Tract Urothelial Carcinoma
  18. An update on genetically engineered mouse models of pancreatic neuroendocrine neoplasms
  19. Clinicopathological features of head and neck cutaneous basal cell carcinoma observed at the Centro Hospitalar de Trás-os-Montes e Alto Douro ENT Department
  20. Characterisation of an Atrx Conditional Knockout Mouse Model: Atrx Loss Causes Endocrine Dysfunction Rather Than Pancreatic Neuroendocrine Tumour
  21. Primary adrenal angiosarcoma within a hematoma
  22. Connexin Expression in Pituitary Adenomas and the Effects of Overexpression of Connexin 43 in Pituitary Tumor Cell Lines
  23. Colonic Pseudolipomatosis: A Rare and Challenging Condition
  24. Predictive Biomarkers in Melanoma: Detection of BRAF Mutation Using Dermoscopy
  25. <b><i>TERT</i></b> Promoter Mutational Status in the Management of Cutaneous Melanoma: Comparison with Sentinel Lymph Node Biopsy
  26. TERTp mutations and p53 expression in head and neck cutaneous basal cell carcinomas with different aggressive features
  27. Combinatorial Therapies to Overcome BRAF/MEK Inhibitors Resistance in Melanoma Cells: An in vitro Study
  28. The role of c-Met and VEGFR2 in glioblastoma resistance to bevacizumab
  29. LRP1B Expression as a Putative Predictor of Response to Pegylated Liposomal Doxorubicin Treatment in Ovarian Cancer
  30. Mohs Micrographic Surgery for Head and Neck Nonmelanoma Skin Cancer: An Approach for Ent Surgeons
  31. Hepcidin-Mediated Hypoferremia Disrupts Immune Responses to Vaccination and Infection
  32. Clinical characteristics and incidence of glucose metabolism disorders during the follow-up of surgically treated insulinomas
  33. Metabolic modulation combined with mTOR pathway inhibition may overcame cutaneous melanoma resistance to MAPK inhibitors treatment
  34. Cutaneous Angiosarcoma in an Unusual Location and Without Predisposing Factors
  35. Embryonal Tumors of the Central Nervous System
  36. Predictive Biomarkers and Patient Outcome in Platinum-Resistant (PLD-Treated) Ovarian Cancer
  37. Prognostic Significance of RAS Mutations and P53 Expression in Cutaneous Squamous Cell Carcinomas
  38. Erratum to “Gastroenteropancreatic Neuroendocrine Neoplasia Characterization in Portugal: Results from the NETs Study Group of the Portuguese Society of Endocrinology, Diabetes and Metabolism”
  39. Molecular Genetic Features of Primary Nonurachal Enteric-type Adenocarcinoma, Urachal Adenocarcinoma, Mucinous Adenocarcinoma, and Intestinal Metaplasia/Adenoma: Review of the Literature and Next-generation Sequencing Study
  40. Regulation of invasion and peritoneal dissemination of ovarian cancer by mesothelin manipulation
  41. A 30-Year Long-Term Experience in Appendix Neuroendocrine Neoplasms—Granting a Positive Outcome
  42. Head and neck cutaneous basal cell carcinoma: what should the otorhinolaryngology head and neck surgeon care about?
  43. A leg ulcer with hard, yellow projections
  44. Juvenile gangrenous vasculitis of the scrotum – a diagnosis not to forget
  45. Loss of SPINT2 expression frequently occurs in glioma, leading to increased growth and invasion via MMP2
  46. Gastroenteropancreatic Neuroendocrine Neoplasia Characterization in Portugal: Results from the NETs Study Group of the Portuguese Society of Endocrinology, Diabetes and Metabolism
  47. Genetic variants identified by target next-generation sequencing in heart transplant patients with dilated cardiomyopathy
  48. Genetic variants identified by target next-generation sequencing in heart transplant patients with dilated cardiomyopathy
  49. TERT promoter mutations are associated with poor prognosis in cutaneous squamous cell carcinoma
  50. Perianal purpuric plaques revealing an amyloid light-chain amyloidosis: case report and review of the literature
  51. Periocular Sebaceous Carcinoma With Apocrine Differentiation: A Case Report and Review of the Literature
  52. Les mutations du promoteur de la télomérase sont un biomarqueur pronostique dans le carcinome épidermoïde cutané
  53. Histological Subtypes and Clinical Behavior Evaluation of Salivary Gland Tumors
  54. The genetics of cutaneous squamous cell carcinogenesis
  55. An unusual case of epistaxis due to angiofibroma of the nasal cavity
  56. Cutaneous amyloidosis as major manifestation of systemic AL-amyloidosis
  57. Melanoma treatment in review
  58. Telomere Maintenance Mechanisms in Cancer
  59. Phenotypic Intratumoral Heterogeneity of Endometrial Carcinomas
  60. Peritoneal dissemination of ovarian cancer: role of MUC16-mesothelin interaction and implications for treatment
  61. Malignant Solitary Fibrous Tumor of the Liver:AIRP Best Cases in Radiologic-Pathologic Correlation
  62. Liver transplant recipients have a higher prevalence of anal squamous intraepithelial lesions
  63. Primary intimal sarcoma of the left atrium presenting with constitutional symptoms
  64. SDHD promoter mutations are rare events in cutaneous melanomas but SDHD protein expression is downregulated in advanced cutaneous melanoma
  65. Epigenetics in endometrial carcinogenesis – part 2: histone modifications, chromatin remodeling and noncoding RNAs
  66. Jejunum/ ileum Neuroendocrine Tumours: results of a multicentric retrospective study
  67. Epigenetics in endometrial carcinogenesis – part 1: DNA methylation
  68. The role of pathology in the management of patients with endometrial carcinoma
  69. Genetic disruption of NRF2 promotes the development of necroinflammation and liver fibrosis in a mouse model of HFE-hereditary hemochromatosis
  70. Genetic polymorphisms in key hypoxia-regulated downstream molecules and phenotypic correlation in prostate cancer
  71. Adipose Tissue Tumors, Stomach
  72. C-Kit (CD117), Gastrointestinal Stromal Tumors (GISTs)
  73. Distant Metastases in Uterine Leiomyosarcomas
  74. Gastrointestinal Autonomic Nerve Tumor
  75. Gastrointestinal Stromal Tumor
  76. Glomus Tumor, Gastrointestinal
  77. Granular Cell Tumor, Gastrointestinal
  78. Inflammatory Fibroid Polyp, Upper Gastrointestinal Tract
  79. Inflammatory Myofibroblastic Tumor, Upper Gastrointestinal Tract
  80. Neuroendocrine Tumor, Esophagus
  81. Neuroendocrine Tumor, Gastric
  82. Neuroendocrine neoplasms: a brief overview emphasizing gastroenteropancreatic tumors
  83. Neurocristic hamartoma of the scalp
  84. Solitary squamoid cyst of the liver
  85. Pathologic Findings in Prophylactic and Nonprophylactic Hysterectomy Specimens of Patients With Lynch Syndrome
  86. TERT promoter mutations in pancreatic endocrine tumours are rare and mainly found in tumours from patients with hereditary syndromes
  87. Spitz/Reed nevi: a review of clinical-dermatoscopic and histological correlation
  88. The prognostic impact of TERT promoter mutations in glioblastomas is modified by the rs2853669 single nucleotide polymorphism
  89. TERT promoter mutations in pancreatic endocrine tumours are frequent in tumours from patients with hereditary syndromes
  90. Metanephric adenoma: Cytological, histological, and molecular diagnosis of a case
  91. Mixed Adenoneuroendocrine Carcinoma Causing Colonic Intussusception
  92. Assessing sirtuin expression in endometrial carcinoma and non-neoplastic endometrium
  93. Basal cell carcinoma of the skin (part 1): epidemiology, pathology and genetic syndromes
  94. Basal cell carcinoma of the skin (part 2): diagnosis, prognosis and management
  95. “A book should not be judged by its cover”: two cases of intestinal adenocarcinoma as the first manifestation of Crohn’s disease
  96. Endometrial Endometrioid Carcinoma Metastases Show Decreased ER-Alpha and PR-A Expression Compared to Matched Primary Tumors
  97. Overexpression of pyruvate dehydrogenase kinase supports dichloroacetate as a candidate for cutaneous melanoma therapy
  98. LÚPUS ERITEMATOSO CUTÂNEO - CORRELAÇÃO CLÍNICOPATOLÓGICA DE MANIFESTAÇÕES CUTÂNEAS ESPECÍFICAS
  99. RE: TERT Promoter Mutation Status as an Independent Prognostic Factor in Cutaneous Melanoma
  100. Endometrial Carcinoma in Portugal
  101. A transcriptomic signature mediated by HOXA9 promotes human glioblastoma initiation, aggressiveness and resistance to temozolomide
  102. Pathophysiology of Infantile Pulmonary Arterial Hypertension Induced by Monocrotaline
  103. Pathology, therapy and prognosis of papillary renal carcinoma
  104. AIRP Best Cases in Radiologic-Pathologic Correlation: Gastroblastoma: A Rare Biphasic Gastric Tumor
  105. Low frequency of TERT promoter mutations in gastrointestinal stromal tumors (GISTs)
  106. Evaluation of colon cancer histomorphology: a comparison between formalin and PAXgene tissue fixation by an international ring trial
  107. TERT Promoter Mutations in Skin Cancer: The Effects of Sun Exposure and X-Irradiation
  108. Telomerase promoter mutations in cancer: an emerging molecular biomarker?
  109. Prognostic significance of TERT promoter mutations in follicular cell-derived thyroid carcinomas
  110. Transcription factor NRF2 protects mice against dietary iron-induced liver injury by preventing hepatocytic cell death
  111. Mitochondrial D310 D-Loop instability and histological subtypes in radiation-induced cutaneous basal cell carcinomas
  112. Human papillomaviruses in intraepithelial neoplasia and squamous cell carcinoma of the conjunctiva
  113. PNET with neuroendocrine differentiation of the lung
  114. Tactoid body features in a Schwann cell hamartoma of colonic mucosa
  115. Frequency of TERT promoter mutations in human cancers
  116. GNAQ and BRAF mutations show differential activation of the mTOR pathway in human transformed cells
  117. Feasibility of Fine-Needle Aspiration in the Diagnosis of Two Unusual Childhood Jaw Tumor Types: Prognoma and Cementifying Fibroma
  118. Analysis of a synchronous gliosarcoma and meningioma with long survival: A case report and review of the literature
  119. Multiple Hepatic Inflammatory Pseudotumours Diagnosed after Laparoscopic Excisional Biopsy
  120. Simultaneous presentation of Kaposi sarcoma and HHV8-associated large B-cell lymphoma in the same lymph node: A rare diagnosis in an HIV-negative patient
  121. Front & Back Matter
  122. Loss of WNK2 expression by promoter gene methylation occurs in adult gliomas and triggers Rac1-mediated tumour cell invasiveness
  123. Human periprostatic white adipose tissue is rich in stromal progenitor cells and a potential source of prostate tumor stroma
  124. Molecular alterations and expression of succinate dehydrogenase complex in wild-type KIT/PDGFRA/BRAF gastrointestinal stromal tumors
  125. Oral squamous cell carcinoma in a Crohn's disease patient taking azathioprine: Case report and review of the literature
  126. mTOR Pathway Overactivation in BRAF Mutated Papillary Thyroid Carcinoma
  127. 295 Protein Kinase WNK2 Was Correlated With Poor Outcome and Malignant Behavior in Glioma Cell Lines
  128. Insights into melanoma: targeting the mTOR pathway for therapeutics
  129. Surgical Treatment of Gastrointestinal Stromal Tumors (GISTs)
  130. The mTOR Signalling Pathway in Human Cancer
  131. Melanocytic Tumour in a Black Sheep never exposed to Ultraviolet Radiation
  132. Downregulation of RKIP Is Associated with Poor Outcome and Malignant Progression in Gliomas
  133. A Clear Cell Renal Cell Carcinoma Inhibiting the Response to Intravitreal Antivascular Endothelial Growth Factor Therapy in Wet Age-Related Macular Disease
  134. Paraganglioma of seminal vesicle and chromophobe renal cell carcinoma: a case report and literature review
  135. ENETS Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Neoplasms: Colorectal Neuroendocrine Neoplasms
  136. ENETS Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Neoplasms: Functional Pancreatic Endocrine Tumor Syndromes
  137. ENETS Consensus Guidelines for the Management of Patients with Gastroduodenal Neoplasms
  138. ENETS Consensus Guidelines for the Management of Patients with Liver and Other Distant Metastases from Neuroendocrine Neoplasms of Foregut, Midgut, Hindgut, and Unknown Primary
  139. ENETS Consensus Guidelines for the Management of Patients with Neuroendocrine Neoplasms from the Jejuno-Ileum and the Appendix Including Goblet Cell Carcinomas
  140. ENETS Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Neoplasms of the Digestive System: Well-Differentiated Pancreatic Non-Functioning Tumors
  141. Author Index Vol. 95, No. 2
  142. A novel germline SDHB mutation in a gastrointestinal stromal tumor patient without bona fide features of the Carney–Stratakis dyad
  143. Abdominal inflammatory myofibroblastic tumor
  144. Endometrial Carcinomas
  145. Ascites as a Presenting Sign of Disseminated Tuberculosis in an Immunocompetent Patient
  146. Impact of EGFR Genetic Variants on Glioma Risk and Patient Outcome
  147. Plenary Oral Free Paper Sessions
  148. Black esophagus
  149. Vascular Ehlers-Danlos syndrome: A case with fatal outcome
  150. Human Endometrium Ultrastructure During the Implantation Window
  151. Identification of De Novo Germline Mutations in the HRPT2 Gene in Two Apparently Sporadic Cases with Challenging Parathyroid Tumor Diagnoses
  152. Dysplasia surveillance in an ulcerative colitis patient: Successful detection with Narrow band imaging and magnification
  153. Sarcoma pleomórfico primário do pulmão — 11 anos de sobrevivência
  154. Primary pleomorphic sarcoma of lung – 11 year survival
  155. mTOR pathway activation in cutaneous melanoma is associated with poorer prognosis characteristics
  156. Analysis of GNAQ mutations, proliferation and MAPK pathway activation in uveal melanomas
  157. Idiopathic Infantile Arterial Calcification: A Rare Cause of Sudden Unexpected Death in Childhood
  158. 78 Analysis of raf kinase inhibitor protein (RKIP) expression as a prognostic marker for glioblastomas
  159. 95 Associations between functional EGFR polymorphisms and glioma risk
  160. Endometrial endometrioid adenocarcinoma associated with primitive neuroectodermal tumour of the uterus: a poor prognostic subtype of uterine tumours
  161. Prognostic value of MGMT promoter methylation in glioblastoma patients treated with temozolomide-based chemoradiation: A Portuguese multicentre study
  162. Evaluation of the mTOR pathway in ocular (uvea and conjunctiva) melanoma
  163. Angiogenesis and Breast Cancer
  164. ENETS Consensus Guidelines for the Management of Bone and Lung Metastases from Neuroendocrine Tumors
  165. ENETS Consensus Guidelines for the Management of Peritoneal Carcinomatosis from Neuroendocrine Tumors
  166. ENETS Consensus Guidelines for the Management of Brain, Cardiac and Ovarian Metastases from Neuroendocrine Tumors
  167. Author Index Vol. 91, 2010
  168. Densidade microvascular e prognóstico de tumores neuro-endócrinos gastro-entero-pancreáticos
  169. Requisitos mínimos para um relatório de Anatomia Patológica de tumores neuroendócrinos.
  170. Contents Vol. 91, 2010
  171. Subject Index Vol. 91, 2010
  172. Effects of Diabetes Mellitus, Pressure-Overload and Their Association on Myocardial Structure and Function
  173. Expression, mutation and copy number analysis of platelet-derived growth factor receptor A (PDGFRA) and its ligand PDGFA in gliomas
  174. Loss of RKIP expression is associated with poor survival in GISTs
  175. Epidermolytic hyperkeratosis with palmoplantar keratoderma in a patient with KRT10 mutation
  176. Low frequency of MAP kinase pathway alterations inKITandPDGFRAwild-type GISTs
  177. Low-Grade Endometrial Stromal Sarcoma and Undifferentiated Endometrial Sarcoma: A Comparative Analysis Emphasizing the Importance of Distinguishing Between These Two Groups
  178. TP53 germline mutations in Portugal and genetic modifiers of age at cancer onset
  179. Características clínico-laboratoriais e sobrevida em doentes com tumores neuroendócrinos do estômago
  180. Restrictive dermopathy—a lethal congenital laminopathy. Case report and review of the literature
  181. Cryptic chromosome rearrangement resulting in SYT-SSX2 fusion gene in a monophasic synovial sarcoma
  182. 583 POSTER Analysis of MAP kinase signalling pathway in KIT & PDGFRA wild-type GISTs
  183. Clinicopathological features of 45,X/46,Xidic(Y) mosaicism and therapeutic implications: case report
  184. Surgical Margin Status and Prognosis of Gastrointestinal Stromal Tumor
  185. Clear Cell Change in Colonic Polyps
  186. Composite Adenomatoid Tumor and Myelolipoma of Adrenal Gland: Report of 2 Cases
  187. Epithelial-myoepithelial parotid carcinoma after kidney transplantation
  188. TP53 codon 72 polymorphism in susceptibility, overall survival, and adjuvant therapy response of gliomas
  189. Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Tumors – Well-Differentiated Jejunal-Ileal Tumor/Carcinoma
  190. Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Tumours: Well-Differentiated Colon and Rectum Tumour/Carcinoma
  191. Consensus Guidelines for the Management of Patients with Liver Metastases from Digestive (Neuro)endocrine Tumors: Foregut, Midgut, Hindgut, and Unknown Primary
  192. Author Index Vol. 87, No. 1, 2008
  193. Title Page / Table of Contents
  194. Poorly-Differentiated Endocrine Carcinomas of Midgut and Hindgut Origin
  195. Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Tumours: Well-Differentiated Tumour/Carcinoma of the Appendix and Goblet Cell Carcinoma
  196. Splenic hamartomas in a dog
  197. Molecular alterations of KIT and PDGFRA in GISTs: evaluation of a Portuguese series
  198. TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system
  199. A subset of colorectal carcinomas express c-KIT protein independently of BRAF and/or KRAS activation
  200. Association between Functional EGF+61 Polymorphism and Glioma Risk
  201. Multiple Myeloma Presenting with Malabsorption
  202. Gastrinoma (Duodenal and Pancreatic)
  203. Poorly Differentiated Carcinomas of the Foregut (Gastric, Duodenal and Pancreatic)
  204. Rare Functioning Pancreatic Endocrine Tumors
  205. Well-Differentiated Duodenal Tumor/Carcinoma (Excluding Gastrinomas)
  206. Well-Differentiated Gastric Tumors/Carcinomas
  207. Well-Differentiated Pancreatic Tumor/Carcinoma: Insulinoma
  208. Orbital Metastasis as a Rare Form of Clinical Presentation of Non-small Cell Lung Cancer
  209. Deep-Seated Congenital Juvenile Xanthogranuloma
  210. Determining the least time required for measuring energy expenditure in premature neonates
  211. An infant with bullous pemphigoid
  212. Molecular Alterations of KIT Oncogene in Gliomas
  213. 183 POSTER Molecular alterations of KIT and PDGFR-alpha; in GISTs - A Portuguese experience
  214. Fluid supplementation for neonatal hyperbilerubinemia
  215. TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system
  216. Identification in Human Brain Tumors of DNA Sequences Specific for SV40 Large T Antigen
  217. Well-Differentiated Pancreatic Nonfunctioning Tumors/Carcinoma
  218. Title Page / Table of Contents
  219. Author Index Vol. 84, No. 3, 2006
  220. Differential Prox-1 and CD 31 expression in mucousae, cutaneous and soft tissue vascular lesions and tumors
  221. Colon stenosis in a patient with ulcerative colitis as a manifestation of mixed müllerian tumor of the peritoneum
  222. Gingival Hyperplasia as a First Manifestation of Crohn's Disease
  223. Colonic Gastrointestinal Autonomic Nervous Tumor in a Patient with Crohn’s Disease
  224. Esophageal Gist: Therapeutic implications of an uncommon presentation of a rare tumor
  225. Epithelioid hemangioendothelioma and multiple thoraco-lumbar lateral meningoceles: two rare pathological entities in a patient with NF-1
  226. Molecular Characterization of PDGFR‐α/PDGF‐A and c‐KIT/SCF in Gliosarcomas
  227. Mutation analysis of B-RAF gene in human gliomas
  228. Malignant peripheral nerve sheath tumour-like primary cutaneous malignant melanoma
  229. August 2003: 47-year-old female with a 7-year history of osteomalacia and hypophosphatemia
  230. 31. Biopsia aspirativa transtorácica por agulha fina para o diagnóstico de lesões pulmonares
  231. Lipomatous haemangiopericytoma (adipocytic variant of solitary fibrous tumour) of the thyroid
  232. Pathologic Quiz Case: A 53-Year-Old Man With a Slowly Enlarging Mass in the Right Leg
  233. Primary Cutaneous Malignant Melanoma With Lipoblast-like Cells
  234. Cutaneous Malignant Melanoma: The Great Simulator
  235. Expression of c-met Tyrosine Kinase Receptor Is Biologically and Prognostically Relevant for Primary Cutaneous Malignant Melanomas
  236. Intraclonal diversity in a Sezary syndrome with a differential response to 2-deoxycoformycin of the two lymphoma cell populations
  237. Pathologic Quiz Case: A 36-Year-Old Woman With Muscle Pain and Weakness
  238. Classic Kaposi's sarcoma of the tongue: Case report with emphasis on the differential diagnosis
  239. Idiopathic Perforation of the Gallbladder: A Novel Differential Diagnosis of Acute Abdomen
  240. Idiopathic Perforation of the Gallbladder: A Novel Differential Diagnosis of Acute Abdomen
  241. Differential Ki67 and bcl-2 immunoexpression in solid-glandular and spindle cell components of biphasic synovial sarcoma: a double immunostaining assessment with cytokeratin and vimentin
  242. Carcinoma secretor da mama no adulto: existem parâmetros bem definidos para decisão terapêutica?
  243. Congenital composite hemangioendothelioma: case report and reappraisal of the hemangioendothelioma spectrum
  244. Response to Cyclosporine in a Patient With Disseminated Granuloma Annulare Associated With CD4+/CD8+(dim)/CD56+ Large Granular Lymphocytic Leukemia
  245. Chronic Eosinophilic Leukaemia Presenting with Erythroderma, Mild Eosinophilia and Hyper-IgE: Clinical, Immunological and Cytogenetic Features and Therapeutic Approach
  246. Hyaline Cell-rich Chondroid Syringoma: Case Report and Review of the Literature
  247. Subject Index, Vol. 107, No. 2, 2002
  248. Cutaneous alternariosis by Alternaria chartarum in a renal transplanted patient
  249. Primary acinic cell-like carcinoma of the breast-a variant with good prognosis?
  250. Genetic Profile of Gliosarcomas
  251. Adenocarcinoma of the cervix
  252. Microsatellite instability is not associated with degree of malignancy and p53 expression of gastrointestinal stromal tumours
  253. Esophageal inflammatory pseudotumor associated with a pseudodiverticulosis cyst: two inter-related lesions?
  254. Time of remodelling of the patella tendon graft in anterior cruciate ligament surgery: an histological and immunohistochemical study in a rabbit model
  255. Synovial sarcoma. Evaluation of Prognosis with Emphasis on the Study of DNA Ploidy and Proliferation (PCNA and Ki‐67) Markers
  256. Nuclear localization of SYT, SSX and the synovial sarcoma-associated SYT-SSX fusion proteins
  257. Synovial sarcoma: immunohistochemical expression of p-glycoprotein and glutathione s-transferase-pi and clinical drug resistance
  258. Critical Commentary
  259. Critical Commentary
  260. Proliferative Activity of Synovial Sarcoma: An Immunohistochemical Evaluation of Ki-67 Labeling Indices of 52 Primary and Recurrent Tumors
  261. Immunohistochemical Profile of Synovial Sarcoma with Emphasis on the Epithelial-type Differentiation
  262. Phacolytic glaucoma and lens-induced uveitis
  263. Critical Commentary
  264. Critical Commentary
  265. Primary liver cancer in genetic hemochromatosis: A clinical, pathological, and pathogenetic study of 54 cases
  266. The Ultrastructural Spectrum of Synovial Sarcomas: A Study of the Epithelial Type Differentiation of Primary Tumors, Recurrences, and Metastases
  267. Congenital Hereditary Corneal Dystrophy: Histologic and Ultrastructural Assessment of a Peculiar Polimorphic Recessive Form
  268. Dermatofibrosarcoma Protuberans
  269. Round cell sarcoma after clear cell sarcoma remission
  270. Thymic Tumors
  271. Abnormal Organization of the Human Retina in a Genetic Disorder (Bloch-Sulzberger Syndrome)
  272. Cytogenetic study of a sclerosing stromal tumor of the ovary
  273. Common arterial trunk associated with absence of one atrioventricular connexion